Key points are not available for this paper at this time.
The heterogeneous state and federal insurance laws for oncology clinical trial coverage are confusing for health care providers, patients, and other stakeholders. Clearer explication and education about clinical trial coverage are needed to improve patient access.
Obeng‐Gyasi et al. (Fri,) studied this question.